Literature DB >> 15628701

Outcome of patients with nonstenotic, nonfistulizing Crohn's disease.

Pilar Nos1, Vicente Garrigues, Guillermo Bastida, Nuria Maroto, Marta Ponce, Julio Ponce.   

Abstract

The nonstenotic, nonfistulizing (or inflammatory) pattern of Crohn's disease appears to be unstable in time and may evolve toward either the stenotic or the fistulizing pattern. We aimed to assess the course of the inflammatory disease and its relation to certain clinical characteristics. After a mean follow-up of 93 months, we evaluated 73 patients with an inflammatory pattern. The behavior trend and its relation to disease location, initial treatment, and need for corticosteroids, immunosuppressors, and surgical resection were analyzed. In 64% of the patients the inflammatory pattern did not change, while in 14 and 22% it evolved toward a stenotic and a fistulizing pattern, respectively. This change was mainly determined by the appearance of perianal disease (75%). The mean time to behavior evolution was 67 months. Most patients required corticosteroids (92%). Need for immunosuppressors (48%) and surgical resection (30%) was significantly greater (P < 0.05) among patients with a change in pattern than in those with persistent inflammatory disease. The inflammatory pattern of CD remains stable in about half of patients. The course of this pattern is not indolent, however, since the needs for immunosuppression and surgical resection during follow-up are considerable.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15628701     DOI: 10.1007/s10620-004-9568-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

Review 1.  Diagnosis and treatment of perianal fistulas in Crohn disease.

Authors:  D A Schwartz; J H Pemberton; W J Sandborn
Journal:  Ann Intern Med       Date:  2001-11-20       Impact factor: 25.391

2.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.

Authors:  E A Vasiliauskas; L Y Kam; L C Karp; J Gaiennie; H Yang; S R Targan
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

3.  The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease.

Authors:  M Sans; D Tàssies; M Pellisé; G Espinosa; L Quintó; J M Piqué; J C Reverter; J Panés
Journal:  Aliment Pharmacol Ther       Date:  2003-04       Impact factor: 8.171

4.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

5.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.

Authors:  A J Greenstein; P Lachman; D B Sachar; J Springhorn; T Heimann; H D Janowitz; A H Aufses
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

6.  Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity.

Authors:  F T Veloso; J T Ferreira; L Barros; S Almeida
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

Review 7.  Treatment of fistulizing Crohn's disease.

Authors:  G R Lichtenstein
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

Review 8.  Azathioprine: state of the art in inflammatory bowel disease.

Authors:  W J Sandborn
Journal:  Scand J Gastroenterol Suppl       Date:  1998

Review 9.  The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review.

Authors:  E V Loftus; P Schoenfeld; W J Sandborn
Journal:  Aliment Pharmacol Ther       Date:  2002-01       Impact factor: 8.171

10.  Validation of a simplified clinical index to predict evolving patterns in Crohn's disease.

Authors:  Pilar Nos; Joaquín Hinojosa; Julio Mora; Vicente Garrigues; Julio Ponce
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 2.566

View more
  3 in total

1.  Evaluation of "top-down" treatment of early Crohn's disease by double balloon enteroscopy.

Authors:  Rong Fan; Jie Zhong; Zheng-Ting Wang; Shu-Yi Li; Jie Zhou; Yong-Hua Tang
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

2.  Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.

Authors:  Kátia Simone Cezário de Barros; Cristina Flores; Luciana Harlacher; Carlos Fernando Magalhães Francesconi
Journal:  Dig Dis Sci       Date:  2017-07-26       Impact factor: 3.199

3.  Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.

Authors:  Kelvin T Thia; William J Sandborn; William S Harmsen; Alan R Zinsmeister; Edward V Loftus
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.